NCT02668588View on ClinicalTrials.gov

Extended-release of Octreotide (LF-PB) for the Treatment of Seroma

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 22, 2015

Primary Completion Date

July 19, 2016

Study Completion Date

July 19, 2016

Conditions
Seroma
Interventions
DRUG

extended release of octreotide

1 intramuscular injection of extended release of octreotide 30 mg

DRUG

extended release of placebo

1 intramuscular injection of extended release of placebo

Trial Locations (7)

10126

Az. Osp. Univ. Città Della Salute e Della Scienza di Torino, Turin

16132

IRCCS Azienda Ospedaliera Universitaria San Martino, Genoa

41124

Az.Osp. Univ. Policlinico di Modena, Modena

43126

Az. Osp. Univ. di Parma, Parma

44124

Az. Osp. Univ. di Ferrara - Ospedale di Cona, Ferrara

80131

IRCCS Fondazione Pascale, Naples

88100

Az. Osp. Univ. Mater Domini, Catanzaro

All Listed Sponsors
lead

Chemi S.p.A.

INDUSTRY

NCT02668588 - Extended-release of Octreotide (LF-PB) for the Treatment of Seroma | Biotech Hunter | Biotech Hunter